Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases

Glioblastoma (GBM) remains an incurable disease with an extremely high five-year recurrence rate. We studied apoptosis in glioma stem cells (GSCs) in response to HDAC inhibition (HDACi) combined with MEK1/2 inhibition (MEKi) or BCL-2 family inhibitors. MEKi effectively combined with HDACi to suppres...

Full description

Bibliographic Details
Main Authors: Aran Merati, Spandana Kotian, Alexus Acton, William Placzek, Erin Smithberger, Abigail K. Shelton, C. Ryan Miller, Josh L. Stern
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/18/13688
_version_ 1797579703781949440
author Aran Merati
Spandana Kotian
Alexus Acton
William Placzek
Erin Smithberger
Abigail K. Shelton
C. Ryan Miller
Josh L. Stern
author_facet Aran Merati
Spandana Kotian
Alexus Acton
William Placzek
Erin Smithberger
Abigail K. Shelton
C. Ryan Miller
Josh L. Stern
author_sort Aran Merati
collection DOAJ
description Glioblastoma (GBM) remains an incurable disease with an extremely high five-year recurrence rate. We studied apoptosis in glioma stem cells (GSCs) in response to HDAC inhibition (HDACi) combined with MEK1/2 inhibition (MEKi) or BCL-2 family inhibitors. MEKi effectively combined with HDACi to suppress growth, induce cell cycle defects, and apoptosis, as well as to rescue the expression of the pro-apoptotic BH3-only proteins BIM and BMF. A RNAseq analysis of GSCs revealed that HDACi repressed the pro-survival BCL-2 family genes MCL1 and BCL-XL. We therefore replaced MEKi with BCL-2 family inhibitors and observed enhanced apoptosis. Conversely, a ligand for the cancer stem cell receptor CD44 led to reductions in BMF, BIM, and apoptosis. Our data strongly support further testing of HDACi in combination with MEKi or BCL-2 family inhibitors in glioma.
first_indexed 2024-03-10T22:40:51Z
format Article
id doaj.art-05ba987375ae444995b4beb91d5aa079
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T22:40:51Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-05ba987375ae444995b4beb91d5aa0792023-11-19T11:01:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-09-0124181368810.3390/ijms241813688Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone DeacetylasesAran Merati0Spandana Kotian1Alexus Acton2William Placzek3Erin Smithberger4Abigail K. Shelton5C. Ryan Miller6Josh L. Stern7Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USADepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USADepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USADepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USAO’Neal Comprehensive Cancer Center, Birmingham, AL 35294, USAO’Neal Comprehensive Cancer Center, Birmingham, AL 35294, USAO’Neal Comprehensive Cancer Center, Birmingham, AL 35294, USADepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USAGlioblastoma (GBM) remains an incurable disease with an extremely high five-year recurrence rate. We studied apoptosis in glioma stem cells (GSCs) in response to HDAC inhibition (HDACi) combined with MEK1/2 inhibition (MEKi) or BCL-2 family inhibitors. MEKi effectively combined with HDACi to suppress growth, induce cell cycle defects, and apoptosis, as well as to rescue the expression of the pro-apoptotic BH3-only proteins BIM and BMF. A RNAseq analysis of GSCs revealed that HDACi repressed the pro-survival BCL-2 family genes MCL1 and BCL-XL. We therefore replaced MEKi with BCL-2 family inhibitors and observed enhanced apoptosis. Conversely, a ligand for the cancer stem cell receptor CD44 led to reductions in BMF, BIM, and apoptosis. Our data strongly support further testing of HDACi in combination with MEKi or BCL-2 family inhibitors in glioma.https://www.mdpi.com/1422-0067/24/18/13688glioblastomaapoptosisHDAC inhibitorBIMBMFBCL-2 family
spellingShingle Aran Merati
Spandana Kotian
Alexus Acton
William Placzek
Erin Smithberger
Abigail K. Shelton
C. Ryan Miller
Josh L. Stern
Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
International Journal of Molecular Sciences
glioblastoma
apoptosis
HDAC inhibitor
BIM
BMF
BCL-2 family
title Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
title_full Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
title_fullStr Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
title_full_unstemmed Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
title_short Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
title_sort glioma stem cells are sensitized to bcl 2 family inhibition by compromising histone deacetylases
topic glioblastoma
apoptosis
HDAC inhibitor
BIM
BMF
BCL-2 family
url https://www.mdpi.com/1422-0067/24/18/13688
work_keys_str_mv AT aranmerati gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT spandanakotian gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT alexusacton gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT williamplaczek gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT erinsmithberger gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT abigailkshelton gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT cryanmiller gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases
AT joshlstern gliomastemcellsaresensitizedtobcl2familyinhibitionbycompromisinghistonedeacetylases